MacIej Gasior

Maciej Gasior, MD, PhD, currently serves as Executive Director of Clinical Development at Supernus Pharmaceuticals, Inc. since February 2025. In addition, Maciej has been an Adjunct Professor at Drexel University College of Medicine since April 2010. Prior roles include Senior Vice President of Clinical Development & Pharmacovigilance and Vice President of Clinical Development at Marinus Pharma, where Maciej focused on rare neurological and psychiatric disorders. Experience spans multiple pharmaceutical companies, including Teva Pharmaceuticals, Bristol-Myers Squibb, and Cephalon, with expertise in CNS and pain therapeutic areas. Academic background encompasses a post-doctoral fellowship in Behavioral Pharmacology from Harvard Medical School and a PhD in Pharmacology from the School of Medicine in Lublin, Poland.